Lee S H, Chen S A, Tai C T, Chiang C E, Wen Z C, Cheng J J, Ding Y A, Chang M S
Department of Medicine and Institute of Clinical Medicine, National Yang-Ming University, Veterans General Hospital, Taipei, Taiwan, Republic of China.
J Am Coll Cardiol. 1998 Mar 1;31(3):637-44. doi: 10.1016/s0735-1097(97)00530-5.
This study compared the long-term effects of complete atrioventricular junction (AVJ) ablation with those of AVJ modification in patients with medically refractory atrial fibrillation (AF).
Comparisons between the long-term effects of AVJ ablation with those of AVJ modification in patients with medically refractory AF have not been systematically studied.
Sixty patients with medically refractory AF were randomly assigned to receive complete AVJ ablation with permanent pacing or AVJ modification. Subjective perception of quality of life (QOL) was assessed by a semiquantitative questionnaire before and 1 and 6 months after ablation. Cardiac performance was evaluated by echocardiography and radionuclide angiography within 24 h (baseline) and at 1 and 6 months after ablation.
Both methods were associated with significant improvement in general QOL and a significant reduction in the frequency of major symptoms and symptoms during attacks. The frequency of hospital admission and emergency room visits and antiarrhythmic drug trials significantly decreased after ablation in both groups. However, patients after complete AVJ ablation had a significantly greater improvement in general QOL and a significantly reduced frequency of major symptoms and symptoms during attacks (including palpitation, dizziness, chest oppression, blurred vision and syncope). Left ventricular (LV) systolic function and the ability to perform activities of daily life significantly improved after ablation in patients with depressed LV function in both groups. All improvements after ablation or modification were maintained over the 6-month follow-up period.
AVJ ablation with permanent pacing, as compared with AVJ modification, had a significantly greater ability to decrease the frequency of attacks and the extent of symptoms of AF, and the patients who received this procedure were more satisfied with their general well-being.
本研究比较了完全性房室交界区(AVJ)消融术与房室交界区改良术对药物难治性心房颤动(AF)患者的长期影响。
对于药物难治性AF患者,AVJ消融术与房室交界区改良术的长期效果比较尚未进行系统研究。
60例药物难治性AF患者被随机分配接受完全性AVJ消融术并植入永久起搏器或房室交界区改良术。在消融术前以及消融术后1个月和6个月,通过半定量问卷评估生活质量(QOL)的主观感受。在消融术后24小时(基线)以及1个月和6个月时,通过超声心动图和放射性核素血管造影评估心脏功能。
两种方法均与总体QOL显著改善以及发作时主要症状和症状频率显著降低相关。两组消融术后住院和急诊就诊频率以及抗心律失常药物试验次数均显著减少。然而,完全性AVJ消融术后患者的总体QOL改善更为显著,发作时主要症状和症状(包括心悸、头晕、胸闷、视力模糊和晕厥)频率显著降低。两组左心室(LV)功能不全患者消融术后LV收缩功能和日常生活活动能力均显著改善。消融或改良术后的所有改善在6个月随访期内均得以维持。
与房室交界区改良术相比,完全性AVJ消融术联合永久起搏在降低AF发作频率和症状程度方面具有显著更强的能力,接受该手术的患者对其总体健康状况更满意。